 |
2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl) methoxy)benzaldehyde |
|---|---|
| Trade Name | |
| Orphan Indication | Sickle cell anemia |
| USA Market Approval | USA |
| USA Designation Date | 2015-12-29 00:00:00 |
| Sponsor | Global Blood Therapeutics, Inc.;400 East Jamie Court, Suite 101;South San Francisco, California, 94080 |
Related Access Program